Concepts (226)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Electric Stimulation Therapy | 5 | 2018 | 85 | 1.030 |
Why?
|
| Epilepsy, Temporal Lobe | 12 | 2017 | 93 | 1.000 |
Why?
|
| Electroencephalography | 26 | 2021 | 869 | 0.980 |
Why?
|
| Epilepsy | 11 | 2021 | 890 | 0.880 |
Why?
|
| Anticonvulsants | 4 | 2013 | 391 | 0.870 |
Why?
|
| Epilepsies, Partial | 9 | 2019 | 85 | 0.720 |
Why?
|
| Implantable Neurostimulators | 2 | 2018 | 21 | 0.650 |
Why?
|
| Temporal Lobe | 6 | 2018 | 116 | 0.640 |
Why?
|
| Epilepsy, Post-Traumatic | 4 | 2018 | 13 | 0.590 |
Why?
|
| Death, Sudden | 1 | 2018 | 44 | 0.540 |
Why?
|
| Epilepsy, Frontal Lobe | 5 | 2013 | 9 | 0.530 |
Why?
|
| Brain Injuries | 4 | 2009 | 712 | 0.490 |
Why?
|
| Mental Recall | 1 | 2015 | 142 | 0.440 |
Why?
|
| Brain | 13 | 2019 | 3235 | 0.430 |
Why?
|
| Gyrus Cinguli | 2 | 2013 | 134 | 0.390 |
Why?
|
| Breast Feeding | 1 | 2013 | 234 | 0.360 |
Why?
|
| Deep Brain Stimulation | 4 | 2019 | 456 | 0.350 |
Why?
|
| Seizures | 7 | 2021 | 890 | 0.350 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2013 | 232 | 0.340 |
Why?
|
| Drug Resistant Epilepsy | 3 | 2019 | 274 | 0.320 |
Why?
|
| Periventricular Nodular Heterotopia | 2 | 2019 | 7 | 0.310 |
Why?
|
| Functional Laterality | 6 | 2015 | 183 | 0.290 |
Why?
|
| Developmental Disabilities | 1 | 2013 | 771 | 0.280 |
Why?
|
| Electrocorticography | 2 | 2019 | 63 | 0.280 |
Why?
|
| Coma | 1 | 2007 | 56 | 0.270 |
Why?
|
| Brain Waves | 2 | 2019 | 43 | 0.260 |
Why?
|
| Neurosurgical Procedures | 3 | 2013 | 317 | 0.240 |
Why?
|
| Adult | 32 | 2021 | 31700 | 0.240 |
Why?
|
| Magnetic Resonance Imaging | 13 | 2019 | 3916 | 0.240 |
Why?
|
| Cerebral Cortex | 5 | 2019 | 468 | 0.220 |
Why?
|
| Neuropsychological Tests | 5 | 2015 | 998 | 0.210 |
Why?
|
| Middle Aged | 22 | 2021 | 28892 | 0.200 |
Why?
|
| Male | 34 | 2021 | 65274 | 0.190 |
Why?
|
| Sclerosis | 2 | 2015 | 30 | 0.190 |
Why?
|
| Apolipoproteins E | 1 | 2003 | 188 | 0.190 |
Why?
|
| Female | 30 | 2020 | 71214 | 0.170 |
Why?
|
| Young Adult | 10 | 2018 | 10099 | 0.170 |
Why?
|
| Neurology | 2 | 2015 | 120 | 0.170 |
Why?
|
| Humans | 48 | 2021 | 131759 | 0.170 |
Why?
|
| Electrodes, Implanted | 6 | 2019 | 174 | 0.160 |
Why?
|
| Encephalitis Virus, St. Louis | 1 | 2000 | 20 | 0.160 |
Why?
|
| Neocortex | 2 | 2019 | 71 | 0.160 |
Why?
|
| Encephalitis, St. Louis | 1 | 2000 | 22 | 0.160 |
Why?
|
| Bradycardia | 1 | 2019 | 57 | 0.150 |
Why?
|
| Frameshift Mutation | 1 | 2020 | 202 | 0.150 |
Why?
|
| Motor Cortex | 2 | 1996 | 63 | 0.140 |
Why?
|
| RNA Splicing | 1 | 2020 | 235 | 0.140 |
Why?
|
| Disease Outbreaks | 1 | 2000 | 314 | 0.140 |
Why?
|
| Videotape Recording | 4 | 2004 | 54 | 0.130 |
Why?
|
| Quality Improvement | 2 | 2015 | 707 | 0.130 |
Why?
|
| Adolescent | 18 | 2018 | 20987 | 0.130 |
Why?
|
| RNA-Binding Proteins | 1 | 2020 | 550 | 0.120 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2019 | 600 | 0.120 |
Why?
|
| Prospective Studies | 7 | 2021 | 6507 | 0.120 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2015 | 60 | 0.110 |
Why?
|
| Dominance, Cerebral | 3 | 2017 | 50 | 0.110 |
Why?
|
| Autoimmune Diseases of the Nervous System | 1 | 2015 | 38 | 0.110 |
Why?
|
| Organ Size | 1 | 2015 | 435 | 0.110 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2018 | 314 | 0.100 |
Why?
|
| Status Epilepticus | 2 | 2000 | 157 | 0.100 |
Why?
|
| Nerve Tissue Proteins | 1 | 2020 | 1130 | 0.100 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2020 | 619 | 0.100 |
Why?
|
| Follow-Up Studies | 6 | 2017 | 5297 | 0.100 |
Why?
|
| Memory | 2 | 2009 | 358 | 0.100 |
Why?
|
| Brain Mapping | 5 | 2017 | 390 | 0.100 |
Why?
|
| Aged | 7 | 2019 | 21259 | 0.100 |
Why?
|
| Hippocampus | 3 | 2019 | 806 | 0.100 |
Why?
|
| Treatment Outcome | 9 | 2015 | 12993 | 0.090 |
Why?
|
| Electric Stimulation | 2 | 2011 | 249 | 0.090 |
Why?
|
| Laughter | 1 | 2011 | 9 | 0.090 |
Why?
|
| Unconsciousness | 1 | 2011 | 17 | 0.090 |
Why?
|
| Nephrolithiasis | 1 | 2010 | 14 | 0.080 |
Why?
|
| Practice Guidelines as Topic | 2 | 2015 | 1303 | 0.080 |
Why?
|
| Fructose | 1 | 2010 | 61 | 0.080 |
Why?
|
| Academies and Institutes | 1 | 2011 | 81 | 0.080 |
Why?
|
| Neurons | 1 | 2020 | 1995 | 0.080 |
Why?
|
| Pentobarbital | 1 | 1990 | 21 | 0.080 |
Why?
|
| Phenytoin | 1 | 1990 | 57 | 0.080 |
Why?
|
| Retrospective Studies | 10 | 2015 | 17662 | 0.080 |
Why?
|
| Veterans | 2 | 2021 | 1797 | 0.080 |
Why?
|
| Fear | 1 | 2011 | 195 | 0.080 |
Why?
|
| Heterozygote | 2 | 2020 | 728 | 0.070 |
Why?
|
| Neuroprotective Agents | 1 | 2010 | 161 | 0.070 |
Why?
|
| Anterior Temporal Lobectomy | 1 | 2009 | 11 | 0.070 |
Why?
|
| Benzodiazepines | 1 | 1990 | 110 | 0.070 |
Why?
|
| Diffuse Axonal Injury | 1 | 2009 | 10 | 0.070 |
Why?
|
| Head Injuries, Penetrating | 1 | 2009 | 8 | 0.070 |
Why?
|
| Delivery of Health Care | 1 | 2015 | 682 | 0.070 |
Why?
|
| Rehabilitation Centers | 1 | 2007 | 27 | 0.070 |
Why?
|
| Cicatrix | 1 | 2009 | 127 | 0.070 |
Why?
|
| Quality of Health Care | 1 | 2011 | 411 | 0.070 |
Why?
|
| Memory Disorders | 1 | 2009 | 207 | 0.060 |
Why?
|
| Psychotropic Drugs | 1 | 2007 | 123 | 0.060 |
Why?
|
| Cross-Sectional Studies | 1 | 2015 | 3836 | 0.060 |
Why?
|
| Brain Concussion | 1 | 2009 | 240 | 0.060 |
Why?
|
| Time Factors | 3 | 2015 | 6280 | 0.060 |
Why?
|
| Epilepsy, Complex Partial | 2 | 2017 | 14 | 0.060 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2009 | 613 | 0.060 |
Why?
|
| Recovery of Function | 1 | 2007 | 450 | 0.060 |
Why?
|
| Activities of Daily Living | 1 | 2007 | 409 | 0.060 |
Why?
|
| Age of Onset | 4 | 2000 | 631 | 0.050 |
Why?
|
| Pattern Recognition, Physiological | 1 | 2004 | 4 | 0.050 |
Why?
|
| Wechsler Scales | 1 | 2004 | 19 | 0.050 |
Why?
|
| Clinical Trials as Topic | 1 | 2009 | 1139 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2011 | 2122 | 0.050 |
Why?
|
| Feasibility Studies | 2 | 2017 | 838 | 0.050 |
Why?
|
| Substantia Nigra | 2 | 2000 | 35 | 0.050 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2003 | 138 | 0.050 |
Why?
|
| Glasgow Outcome Scale | 1 | 2003 | 50 | 0.050 |
Why?
|
| Longitudinal Studies | 2 | 2018 | 1518 | 0.050 |
Why?
|
| Drug Implants | 1 | 2002 | 41 | 0.050 |
Why?
|
| Gene Frequency | 1 | 2003 | 750 | 0.040 |
Why?
|
| Epilepsy, Tonic-Clonic | 2 | 2017 | 16 | 0.040 |
Why?
|
| Pregnancy | 1 | 2013 | 7576 | 0.040 |
Why?
|
| Huntington Disease | 1 | 1982 | 142 | 0.040 |
Why?
|
| Phenotype | 2 | 2009 | 4528 | 0.040 |
Why?
|
| Double-Blind Method | 2 | 2015 | 1638 | 0.040 |
Why?
|
| Neurosyphilis | 1 | 2000 | 15 | 0.040 |
Why?
|
| Axon Guidance | 1 | 2020 | 4 | 0.040 |
Why?
|
| AIDS Dementia Complex | 1 | 2000 | 21 | 0.040 |
Why?
|
| Diagnostic Imaging | 1 | 2002 | 301 | 0.040 |
Why?
|
| Receptors, Cell Surface | 1 | 1982 | 432 | 0.040 |
Why?
|
| Penicillins | 1 | 2000 | 154 | 0.040 |
Why?
|
| Brain Edema | 1 | 2000 | 65 | 0.040 |
Why?
|
| Genotype | 2 | 2003 | 2656 | 0.040 |
Why?
|
| Video Recording | 1 | 2021 | 208 | 0.040 |
Why?
|
| Prognosis | 1 | 2009 | 4953 | 0.040 |
Why?
|
| Muscle Hypotonia | 1 | 2020 | 194 | 0.040 |
Why?
|
| Language Development Disorders | 1 | 2020 | 178 | 0.040 |
Why?
|
| Radiography | 1 | 2000 | 762 | 0.040 |
Why?
|
| Frontal Lobe | 2 | 1996 | 116 | 0.040 |
Why?
|
| Alleles | 1 | 2003 | 1711 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 2020 | 314 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2020 | 659 | 0.030 |
Why?
|
| Reproducibility of Results | 2 | 2021 | 2991 | 0.030 |
Why?
|
| DNA | 1 | 2003 | 1442 | 0.030 |
Why?
|
| Angelman Syndrome | 1 | 1998 | 68 | 0.030 |
Why?
|
| Epilepsy, Partial, Motor | 1 | 2017 | 3 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 1998 | 144 | 0.030 |
Why?
|
| Zebrafish | 1 | 2020 | 428 | 0.030 |
Why?
|
| Persian Gulf Syndrome | 1 | 1997 | 16 | 0.030 |
Why?
|
| Long-Term Care | 1 | 2017 | 70 | 0.030 |
Why?
|
| Age Factors | 2 | 2000 | 2872 | 0.030 |
Why?
|
| Defibrillators, Implantable | 1 | 2019 | 214 | 0.030 |
Why?
|
| Central Nervous System Diseases | 1 | 1997 | 99 | 0.030 |
Why?
|
| Electrodes | 2 | 1996 | 81 | 0.030 |
Why?
|
| Base Sequence | 1 | 2020 | 2783 | 0.030 |
Why?
|
| Chromosome Disorders | 1 | 1998 | 317 | 0.030 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 1997 | 137 | 0.030 |
Why?
|
| Chromosome Aberrations | 1 | 1998 | 577 | 0.030 |
Why?
|
| Monitoring, Intraoperative | 1 | 1996 | 130 | 0.030 |
Why?
|
| Child, Preschool | 5 | 2020 | 15051 | 0.030 |
Why?
|
| Immunomodulation | 1 | 2015 | 80 | 0.030 |
Why?
|
| Hospitals, Teaching | 1 | 2015 | 109 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2015 | 192 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2020 | 2969 | 0.030 |
Why?
|
| Propofol | 1 | 1994 | 48 | 0.030 |
Why?
|
| Tomography, Emission-Computed | 1 | 1993 | 36 | 0.020 |
Why?
|
| Intellectual Disability | 1 | 2020 | 1082 | 0.020 |
Why?
|
| Neurologic Examination | 3 | 2000 | 197 | 0.020 |
Why?
|
| Texas | 1 | 2000 | 3622 | 0.020 |
Why?
|
| Brain Neoplasms | 3 | 1994 | 1297 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 3093 | 0.020 |
Why?
|
| Drug Resistance | 1 | 1990 | 252 | 0.020 |
Why?
|
| Risk Factors | 1 | 2003 | 10961 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2000 | 6915 | 0.020 |
Why?
|
| Child | 7 | 2013 | 26307 | 0.020 |
Why?
|
| Educational Status | 1 | 2009 | 281 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2011 | 645 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2011 | 1224 | 0.010 |
Why?
|
| Psychometrics | 1 | 2009 | 677 | 0.010 |
Why?
|
| Automatism | 2 | 1995 | 4 | 0.010 |
Why?
|
| Trauma Severity Indices | 1 | 2004 | 87 | 0.010 |
Why?
|
| Posture | 2 | 1995 | 136 | 0.010 |
Why?
|
| Quality of Life | 1 | 2014 | 2115 | 0.010 |
Why?
|
| Prevalence | 1 | 2010 | 2695 | 0.010 |
Why?
|
| Subdural Space | 2 | 1993 | 3 | 0.010 |
Why?
|
| Mice | 1 | 2020 | 18482 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2004 | 955 | 0.010 |
Why?
|
| Putamen | 1 | 1982 | 21 | 0.010 |
Why?
|
| Subcellular Fractions | 1 | 1982 | 88 | 0.010 |
Why?
|
| Caudate Nucleus | 1 | 1982 | 36 | 0.010 |
Why?
|
| Receptors, GABA-A | 1 | 1982 | 60 | 0.010 |
Why?
|
| Observer Variation | 2 | 1993 | 319 | 0.010 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 1982 | 179 | 0.010 |
Why?
|
| United States | 2 | 2011 | 11812 | 0.010 |
Why?
|
| Animals | 1 | 2020 | 34404 | 0.010 |
Why?
|
| Diagnosis, Differential | 2 | 1995 | 1912 | 0.010 |
Why?
|
| Ligases | 1 | 1998 | 35 | 0.010 |
Why?
|
| Genomic Imprinting | 1 | 1998 | 127 | 0.010 |
Why?
|
| Hematologic Tests | 1 | 1997 | 36 | 0.010 |
Why?
|
| Nystagmus, Pathologic | 1 | 1997 | 23 | 0.010 |
Why?
|
| Vestibular Function Tests | 1 | 1997 | 34 | 0.010 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 1997 | 101 | 0.010 |
Why?
|
| Evoked Potentials | 1 | 1997 | 126 | 0.010 |
Why?
|
| Muscular Diseases | 1 | 1997 | 124 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 1998 | 1069 | 0.010 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 1998 | 364 | 0.010 |
Why?
|
| Ataxia | 1 | 1997 | 169 | 0.010 |
Why?
|
| Chromosome Deletion | 1 | 1998 | 652 | 0.010 |
Why?
|
| Oligodendroglioma | 1 | 1993 | 21 | 0.010 |
Why?
|
| Ganglioglioma | 1 | 1993 | 21 | 0.010 |
Why?
|
| Arm | 1 | 1993 | 74 | 0.010 |
Why?
|
| Speech | 1 | 1993 | 70 | 0.010 |
Why?
|
| Evoked Potentials, Somatosensory | 1 | 1993 | 35 | 0.010 |
Why?
|
| Probability | 1 | 1993 | 310 | 0.010 |
Why?
|
| Head | 1 | 1993 | 115 | 0.010 |
Why?
|
| Deoxyglucose | 1 | 1993 | 42 | 0.010 |
Why?
|
| Astrocytoma | 1 | 1993 | 102 | 0.010 |
Why?
|
| Cognition Disorders | 1 | 1997 | 565 | 0.010 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 1993 | 126 | 0.010 |
Why?
|
| Eye | 1 | 1993 | 227 | 0.010 |
Why?
|
| Dystonia | 1 | 1993 | 174 | 0.010 |
Why?
|
| DNA Methylation | 1 | 1998 | 1087 | 0.010 |
Why?
|
| Monitoring, Physiologic | 1 | 1993 | 371 | 0.010 |
Why?
|
| Preoperative Care | 1 | 1993 | 358 | 0.010 |
Why?
|
| Action Potentials | 1 | 1993 | 471 | 0.000 |
Why?
|
| Equipment Design | 1 | 1992 | 555 | 0.000 |
Why?
|
| Sphenoid Bone | 1 | 1989 | 8 | 0.000 |
Why?
|
| Case-Control Studies | 1 | 1997 | 3451 | 0.000 |
Why?
|
| Scalp | 1 | 1989 | 58 | 0.000 |
Why?
|
| Chronic Disease | 1 | 1993 | 1235 | 0.000 |
Why?
|
| Infant | 2 | 1995 | 13317 | 0.000 |
Why?
|
| Predictive Value of Tests | 1 | 1993 | 2298 | 0.000 |
Why?
|
| Incidence | 1 | 1993 | 3349 | 0.000 |
Why?
|
| Postoperative Complications | 1 | 1993 | 3133 | 0.000 |
Why?
|